Alethea Capital Management, LLC Cidara Therapeutics, Inc. Transaction History

Alethea Capital Management, LLC

  • $138 Million
  • Q3 2024

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$0.64 - $0.92 $18,673 - $26,843
-29,178 Reduced 1.79%
1,598,492 $1.47 Million
Q2 2023

Aug 14, 2023
SELL
$1.01 - $1.42 $50,019 - $70,324
-49,524 Reduced 2.95%
1,627,670 $1.84 Million
Q2 2022

Aug 15, 2022
SELL
$0.43 - $0.91 $112,690 - $238,485
-262,072 Reduced 13.51%
1,677,194 $819,000
Q1 2022

May 13, 2022
BUY
$0.67 - $1.39 $1,488 - $3,088
2,222 Added 0.11%
1,939,266 $1.62 Million
Q4 2021

Feb 14, 2022
BUY
$1.18 - $2.18 $902,700 - $1.67 Million
765,000 Added 65.27%
1,937,044 $2.46 Million
Q2 2021

Aug 16, 2021
BUY
$1.87 - $2.7 $15,732 - $22,715
8,413 Added 0.72%
1,172,044 $2.37 Million
Q1 2021

May 14, 2021
BUY
$2.06 - $3.01 $19,570 - $28,594
9,500 Added 0.82%
1,163,631 $3.1 Million
Q4 2020

Feb 12, 2021
SELL
$1.99 - $3.25 $312 - $510
-157 Reduced 0.01%
1,154,131 $2.31 Million
Q3 2020

Nov 16, 2020
BUY
$2.85 - $4.1 $358,812 - $516,185
125,899 Added 12.24%
1,154,288 $3.29 Million
Q2 2020

Aug 11, 2020
BUY
$2.39 - $4.0 $319,146 - $534,136
133,534 Added 14.92%
1,028,389 $3.8 Million
Q1 2020

May 11, 2020
BUY
$1.74 - $4.26 $575,143 - $1.41 Million
330,542 Added 58.57%
894,855 $2.22 Million
Q1 2019

May 06, 2019
BUY
$2.35 - $3.27 $192,596 - $267,996
81,956 Added 16.99%
564,313 $1.5 Million
Q4 2018

Jan 23, 2019
BUY
$2.1 - $4.5 $94,500 - $202,500
45,000 Added 10.29%
482,357 $1.13 Million
Q3 2018

Oct 29, 2018
BUY
$3.7 - $5.25 $1.21 Million - $1.72 Million
328,263 Added 300.9%
437,357 $1.92 Million
Q2 2018

Jul 17, 2018
BUY
$3.75 - $6.05 $116,992 - $188,747
31,198 Added 40.05%
109,094 $567,000
Q1 2018

Apr 18, 2018
BUY
$4.0 - $8.15 $102,560 - $208,966
25,640 Added 49.07%
77,896 $312,000
Q4 2017

Feb 14, 2018
BUY
$6.35 - $8.75 $331,825 - $457,240
52,256
52,256 $355,000

About Cidara Therapeutics, Inc.

CDTX Quotes by TradingView
  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $1.43B
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track Alethea Capital Management, LLC Portfolio

Follow Alethea Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alethea Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alethea Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email